BioCentury Grand Rounds Europe 2026

BioCentury Grand Rounds Europe 2026

Thesian Bio took part in BioCentury Grand Rounds Europe on 23 September 2026 in Amsterdam. The event brings together emerging European biotech companies with investors and industry leaders.

 

Our team presented our in vivo CAR platform. It engineers T cells, macrophages and dendritic cells from a single intravenous administration, with the aim of overcoming the immunosuppression and antigen escape that limit current therapies in solid tumors. We were glad to share our progress and to meet many of the people building the next generation of cell therapies.

 

To follow up on our program, please contact Oscar Castanon at o.castanon@thesianbio.com.